{"id":17024,"date":"2013-08-30T01:30:00","date_gmt":"2013-08-29T23:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/farmaco-mercato-positivo-a-luglio\/"},"modified":"2013-08-30T01:30:00","modified_gmt":"2013-08-29T23:30:00","slug":"farmaco-mercato-positivo-a-luglio","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaco-mercato-positivo-a-luglio\/","title":{"rendered":"Drug: positive market in July"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; mso-bidi-font-family: BookAntiqua\"><font size=\"3\"><font face=\"Calibri\">Not just information about medicines. In the US, the demand for online services that pharmaceutical companies are expected to provide to help patients manage a chronic condition is growing on the internet. This is what emerges from the &#039;ePharma Consumer 2012&#039; study by the consultancy firm Manhattan Research, conducted among 6,607 Americans aged 18 and over.<\/p>\n<p><\/font><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; mso-bidi-font-family: BookAntiqua\"><font size=\"3\"><font face=\"Calibri\">The 30% of online users with a chronic illness and the 38% of &#039;caregivers&#039; would be interested in a patient support program with a range of services. These include financial assistance, support for food choices, tools to track and manage illness and a hotline to a nurse. <\/p>\n<p><\/font><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; mso-bidi-font-family: BookAntiqua\"><font size=\"3\"><font face=\"Calibri\">The offer of these programs currently varies from disease to disease, for example the 41% of people with multiple sclerosis used one made available by a pharmaceutical company. &quot;Patients are interested in companies&#039; patient advocacy programs, so industry marketers should also consider partnering with providers such as general health websites, pharmacies and hospitals to boost these services,&quot; said Monique Levy, vice president of research at Manhattan Research.<\/p>\n<p><\/font><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><i><span style=\"font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-weight: bold\">January 18, 2013 \u2013 PharmaKronos<\/p>\n<p><\/span><\/i><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Non solo informazioni sui medicinali. Negli Usa, cresce su internet la domanda di servizi on-line che le aziende farmaceutiche dovrebbero fornire per aiutare i pazienti a gestire una condizione cronica. E&#8217; quanto emerge dallo studio &#8216;ePharma Consumer 2012&#8217; della societ&agrave; di consulenza Manhattan Research, condotto tra 6.607 americani di 18 anni e oltre. Il 30% &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17024","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17024"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17024\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17024"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17024"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}